Lucas and Luna explore the rapidly evolving world of digital health, where wearables track vitals, diagnostics shift to at-home testing, and software platforms reshape patient care. Each episode focuses on a specific development: how continuous glucose monitors are changing diabetes management, the FDA's latest clearance for an AI-driven ECG algorithm, or the business models behind telehealth startups like Ro and Hims & Hers. Lucas brings a journalist's precision to the numbers — market sizes, clinical trial results, reimbursement rates — while Luna challenges him on the real-world impact for clinicians and patients. They dissect earnings reports from Apple and Fitbit, parse policy moves from the FDA and CMS, and debate whether VC-funded digital health unicorns can sustain their valuations. Listeners — healthcare professionals, investors, tech strategists — get a clear-eyed briefing on what works, what's hype, and what's next in a sector where staying informed means understanding both the science and the business. How do you separate signal from noise when every startup claims to democratize healthcare?

Support FexingoRSS Feed